SFX by Ex Libris Inc.

Title:	Cancer-gene testing ramps up
Source:	Nature [0028-0836] Callaway, E yr:2010

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Han, Matej u. "DNA damage in oral cancer cells induced by nitrogen atmospheric pressure plasma jets." Applied physics letters 102.23: 233703-233707.
description	2.	"An eye for gene repair.(GENE THERAPY)(blindness and gene therapy)(Brief article)." Nature 482.7383 (2012): 8-.
description	3.	van Diest, E J. "Current technologies for HER2 testing in breast cancer." Critical reviews in oncology/hematology 80.3 (2011): 380-392.
description	4.	Benner, Paul R. "Single-gene testing combined with single nucleotide polymorphism microarray preimplantation genetic diagnosis for aneuploidy: a novel approach in optimizing pregnancy outcome." Fertility and sterility 95.5 (2010): 178600000-4294967295.
description	5.	Brenner, Malcolm K K. "Developing T-cell therapies for cancer in an academic setting." Advances in experimental medicine and biology 610.- (2008): 88-99.
description	6.	Klas, M. "Characteristics of N2and N2/O2atmospheric pressure glow discharges." Plasma sources science & technology 22.2 (2013): 25013-7.
description	7.	Han, William u. "Plasmid DNA damage induced by helium atmospheric pressure plasma jet." The European physical journal. D, Atomic, molecular and optical physics 68.3 (2014): 1-7.
description	8.	Weber, Georg F. "Gene therapy - Why can it fail?" Medical hypotheses 80.5 (2013): 613-6.
description	9.	Feyer, V. "Adsorption of Histidine and a Histidine Tripeptide on Au(111) and Au(110) from Acidic Solution." The journal of physical chemistry. C 116.43 (2012): 22960-22966.
description	10.	Sheridan, C. "Gene therapy finds its niche: gene therapy is finally poised to make a contribution to the treatment of debilitating, highly penetrant genetic diseases that have proved intractable to other regimens.(Report)." Nature biotechnology 29.2 (2011): 121-.
description	11.	"Gene therapy." Nature reviews genetics 5.4 (2004): 247-.
description	12.	"Cancer biology: Two-faced cancer gene." Nature 478.7369 (2011): 288-289.
description	13.	Frantz, S. "Engineered T-cell therapy shows efficacy in blood cancer." Nature biotechnology 29.10 (2011): 853-855.
description	14.	Treff, Nathan R. "Single nucleotide polymorphism microarray-based concurrent screening of 24-chromosome aneuploidy and unbalanced translocations in preimplantation human embryos." Fertility and sterility 95.5 (2011): 1606-161200.
description	15.	Hampton, T. "Gene Therapy for Blindness." JAMA 303.13 (2010): 1245-1245.
description	16.	Oʼgrady, A. "An Immunohistochemical and Fluorescence in Situ Hybridization-based Comparison Between the Oracle HER2 Bond Immunohistochemical System, Dako HercepTest, and Vysis PathVysion HER2 FISH Using Both Commercially Validated and Modified ASCO/CAP and United King." Applied immunohistochemistry & molecular morphology 18.6 (2010): 489-493.
description	17.	Fiorentino, F. "Polymerase chain reaction-based detection of chromosomal imbalances on embryos: the evolution of preimplantation genetic diagnosis for chromosomal translocations." Fertility and sterility 94.6 (2010): 2001-6.
description	18.	Shi, Y. "A Novel Proximity Assay for the Detection of Proteins and Protein Complexes: Quantitation of HER1 and HER2 Total Protein Expression and Homodimerization in Formalin-fixed, Paraffin-Embedded Cell Lines and Breast Cancer Tissue." Diagnostic molecular pathology 18.1 (2009): 11-21.
description	19.	Lo, Y M Dennis M. "Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma." Proceedings of the National Academy of Sciences of the United States of America 105.51 (2008): 20458-63.
description	20.	Munné, S. "The role of preimplantation genetic diagnosis in diagnosing embryo aneuploidy." Current opinion in obstetrics and gynecology 21.5 (2009): 442-449.